Araştırma Makalesi

Clinical symptoms of rat acute peritonitis model and study over effects of oral strontium ranelate administration for the treatment

Cilt: 40 Sayı: 1 20 Mart 2018
PDF İndir
TR EN

Clinical symptoms of rat acute peritonitis model and study over effects of oral strontium ranelate administration for the treatment

Abstract

Objective: Despite the improvements in the treatments of surgical and intensive care, sepsis and systemic inflammatory response syndrome are the most common cause of mortality. Therefore in the experimental animal model, we aimed to reveal biochemical and histopathologic effects of strontium ranelate on healing in experimental animal model for peritonitis and sepsis.

Method: 20 female Wistar-Albino rats were used.Rats were seperated into 4 groups; control, sham [ceacum ligation perforation (CLP)], CLP + Strontium (S) (CLP+S) and S+CLP+S. Rats were euthanised on 7th day. Peritoneal inflammation staging and ileum resection was performed. Blood samples were taken for biochemical screening and IL-1, IL-6, IL-10 and TNF-alpha tests were evaluated.

Results: Peritoneal inflammation score was the  highest at CLP group and the lowest at control group. There was healing in CLP+S group compared to CLP group, and more healing in S+CLP+S group compared to CLP+S group. According to histopathological evaluation, ileum injury was the lowest in the control group and the highest in CLP group. Less injury was found in CLP+S group compared to CLP group, and less injury was found in S+CLP+S group compared  to CLP+S group. No difference was found when TNF-alpha, IL-1, IL-6 and IL-10 values were compared.

Conclusions: Strontium ranelate may reduce mortality and morbidity by prophylactic treatment in patients at risk of sepsis and patients with sepsis.

Keywords

Kaynakça

  1. 1- Pieracci, F.M., Barie, P.S.Intra-abdominal infections. Curr. Opin. Crit. Care 2007;13, 440-9.
  2. 2- Topal F, Yonem O, Tuzcu N, et al. Strontium chloride: canit be a new treatment option for ulcerative colitis? Biomed Res Int 2014: 530687. doi:10.1155/2014/530687.
  3. 3- Collaert B. and Fischer C. “Dentine hypersensitivity: a review,” Endodontics & Dental Traumatology 1991; 7: 145-52.
  4. 4- Autio HKA, Scher I, and Morris MJ. “Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer,” Current Treatment Options in Oncology 2012;13: 174-88.
  5. 5- Huang C, Li L, Yu X. et al. The inhibitory effect of strontiumdoped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro. BiomedicalMaterials 2014; 9, Article ID025010.
  6. 6- Yamaguchi M, Weitzmann MN. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-𝜅B activation.Molecular and Cellular Biochemistry 2012; 359: 399-07.
  7. 7- Buache E, Velard F, Bauden E et al. “Effect of strontium substituted biphasic calcium phosphate on inflammatory mediators production by humanmonocytes,” Acta Biomaterialia 2012; 8: 3113-9.
  8. 8- Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007; 81: 137-43.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Sinan Soylu
Türkiye

Atilla Kurt
Türkiye

Zeynep Deniz Şahin İnan

Hüsnü Çağrı Genç

Hakkı Coşkun

Musa Serin

Yayımlanma Tarihi

20 Mart 2018

Gönderilme Tarihi

18 Kasım 2017

Kabul Tarihi

15 Mart 2018

Yayımlandığı Sayı

Yıl 2018 Cilt: 40 Sayı: 1

Kaynak Göster

AMA
1.Soylu S, Kurt A, İnan ZDŞ, Genç HÇ, Coşkun H, Serin M. Clinical symptoms of rat acute peritonitis model and study over effects of oral strontium ranelate administration for the treatment. CMJ. 2018;40(1):71-77. doi:10.7197/223.vi.356042